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Abstract
The genetic background predisposing pregnant women to pre-eclampsia/eclampsia (PE/E) is
still unknown. The aim of the current study was to investigate whether there is an association
between the TNF-alpha-308 and 850 polymorphisms and PE or eclampsia. In this study, 40 cases
of eclampsia, 113 cases of PE and 80 normotensive control cases were genotyped for the TNF-
alpha-G-308A and C-850 polymorphisms. At position 308, the replacement of Guanine with
Adenosine was denoted as TNF2. We found a significant difference between the TNF2 allele
frequencies of the eclamptic, pre-eclamptic and normotensive controls. TNF2 (AA) polymorphism
frequency was significantly higher among the eclamptics and pre-eclamptics (control : 5%, PE :
13.3%, E : 12.9%). A significantly different genotype distribution of C-850T polymorphism was
observed between the PE/E and control groups, with the frequency of the variant TT genotype
being significantly reduced in the preeclamptics (PE : 17% ; E : 17.5%) when compared with the
control group (24.3%). We have demonstrated an association between TNF-alpha polymorphisms
and pre-eclampsia susceptibility. However, it is not known whether C-850T polymorphism has a
functional effect on the TNF-alpha gene. In addition, it was not possible to determine whether
this polymorphism promotes the progression from PE to eclampsia because of no statistically
significant difference between eclampsia and the controls.
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re-eclampsia (PE) is the most common serious 
medical disorder of human pregnancy with a 
worldwide incidence of 2ﾝ5ｵｴ  It continues to be a 
leading cause of maternal as well as perinatal mor-
bidity and mortalityｴ  PE is diagnosed mainly by the 
new onset of hypertension and proteinuria during the 
latter half of pregnancy andｳ  if untreatedｳ  can prog-
ress to eclampsiaｳ  a particularly serious condition 
which can lead to the death of the motherｳ  the baby 
or bothｴ  The biological factors which determine the 
progression of PE to eclampsia are unknown [1]ｴ
　　Both the etiology and pathogenesis of PE/E 
(eclampsia) are poorly understoodｴ  PE/E is primar-
ily a disease of ﬁ rst pregnancyｳ  and prior exposure 
to paternal antigens appears to have a protective 
eﬀ ectｳ  leading to the widely held view that there is 
involvement of the immune systemｳ  at least in part 
[1]ｴ  A complex genetic basis is suspected with a 
P
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widely held view being that both maternal and pater-
nal genes contribute to susceptibility [2]ｴ  Recent 
genome scans in Icelandic [2] and Australian/New 
Zealand [3] populations have so far conﬁ rmed link-
age to a locus on chromosome 2ｳ  with as yet no obvi-
ous positional candidates identiﬁ edｴ  Endothelial cell 
dysfunction is considered to play a key role in the 
pathophysiology of PE/E [4]ｴ  This contention is 
supported by morphologicalｳ  biochemical and func-
tional observations consistent with endothelial dam-
age or activation [5]ｴ  Inﬂ amatory cytokines have 
been shown to upregulate the gene expression of 
numerous molecules in endothelial cells signaling 
their activation [6]ｴ  A multifunctional cytokineｳ 
tumor necrosis factor ｸ (TNF-ｸ)ｳ  is the principal 
immune mediator derived from macrophages and lym-
phocytesｴ  It has been implicated in the transcrip-
tional regulation of the genes for the potent vasocon-
strictors platelet-derived growth factor and 
endothelin-1 [1ｳ  7ｳ  8]ｴ  TNF-alpha has also been 
shown to induce the expression of plasminogen acti-
vator inhibitor-1 in cultured human endothelial cells 
[9]ｴ  Increased concentrations of endothelin-1 and 
plasminogen activator inhibitor-1 have been found in 
the plasma of PE patientsｳ  and serum from PE 
patients upregulates platelet-derived growth factor 
gene expression in cultured endothelial cells [10]ｴ  
These studies suggest that one mechanism by which 
inﬂ ammatory cytokines such as TNF-ｸ may aﬀ ect 
endothelial cell function in PE is through the upregu-
lation of molecules that have profound eﬀ ects on the 
vasculatureｴ  The gene for TNF-ｸ resides within the 
class 3 region of the major histocompatibility com-
plexｳ  and several polymorphisms in the promoter 
region of the TNF-ｸ gene have been described 
(－1,032ｳ  －863ｳ  －857ｳ  －850ｳ  －575ｳ  －375ｳ 
－308ｳ  －274ｳ  －243ｳ  －237ｳ  －162) [11]ｴ  G-308A 
and C-850T transition polymorphisms within the 
TNF-ｸ gene promoter have been associated with a 
negative outcome in some diseasesｳ  including PEｴ 
The association of the T allele of the C-850T poly-
morphism was found with PEｳ  but its association 
with eclampsia is unknownｴ  The majority of studies 
investigating the functional signiﬁ cance of TNF-ｸ 
promoter polymorphisms have focused on the biallelic 
G to A transition at position －308ｴ  The genetic 
variation on position －308 results in 2 allelic formsｳ 
in which the presence of guanine (G) deﬁ nes the com-
mon variant variationｳ  TNF1 (GG)ｳ  and the presence 
of adenine (A) deﬁ nes the less common variantｳ 
TNF2 (AA) [12]ｴ  The genetic variation on position 
－850 results in 2 allelic formsｳ  in which the pres-
ence of Cytosine (C) deﬁ nes the common variantｳ  CCｳ 
and the presence of Thymidine (T) deﬁ nes the less 
common variantｳ  TTｴ  Taken togetherｳ  these reports 
suggest that the role of TNF-ｸ in the development of 
PE/E is evident but not completely understoodｴ
　　The aim of this study was to investigate whether 
there is an association between the TNF-ｸ-G-308A 
and C-850T polymorphisms and PE or eclampsiaｴ
Materials and Methods
　　Written approval was obtained from the Ethics 
Committee of Cukurova University Hospital and 
informed consent from all patients and controls 
before peripheral blood samples were takenｴ 
Information was collected retrospectively about 113 
preeclampticｳ  40 eclamptic pregnancies of primipa-
rous women and 80 (70 for C-850T and 80 for 
G-308A polymorphism were analysed) normotensive 
control women with no history of preeclampsia who 
delivered at Cukurova University Hospital between 
June 2004 and August 2005ｴ
　　Peeclampsia was deﬁ ned as the development of 
hypertension and new-onset proteinuria (＞300 mg of 
urinary protein in 24 h) in women with no protienuria 
at baselineｴ  Diagnosis was based on clinical assess-
mentｳ  using the criteria of the Report of the National 
High Blood Pressure Education Program Working 
Group on High Blood Pressure in Pregnancyｳ  2000 
[13]ｴ  Pregnant women were considered to have 
severe PE if they had either (1) an increase in sys-
tolic blood pressure of greater than or equal to 25 
mmHg above baseline and/or an increase in diastolic 
blood pressure of greater than or equal to 15 mmHg 
above baselineｳ  or (2) a persistent systolic pressure 
of greater than or equal to 140 mmHg and/or a dia-
stolic pressure of greater than or equal to 90 mmHgｴ 
These levels had to occur on at least 2 occasions 
greater than 0.3 g/l in a 24-hour specimenｳ  or the 
dipstick proteinuria score had to be greater than or 
equal to 2＋ in a random urine collectionｴ  Women 
who met these criteria and who had experienced 
either convulsions or unconsciousness in the perinatal 
period were classiﬁ ed as having had eclampsiaｴ 
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Because PE/E is typically a disease of ﬁ rst pregnan-
cies [1ｳ  14ｳ  15]ｳ  this study was limited only to pri-
migravid patientsｴ  Women with preexisting hyperten-
sionｳ  chronic renal disease or autoimmune disorders 
such as systemic lupus erythematosus known to pre-
dispose them to PE were excludedｴ
　　DNA was extracted from peripheral blood lym-
phocytes by using a standard salting out extraction 
method modiﬁ ed from Millerｾs method [16]ｴ  In the 
methodｳ  0.5 ml of peripheral blood was treated with 
1 ml of erythrocyte lysis buﬀ er (0.32 M sucroseｳ  10 
mM Tris-HCl pH 7.5ｳ  5 mM MgCl2ｳ  1ｵ Triton 
X-100) at room temperature for 5 minｴ  In order to 
collect leukocytesｳ  the mixture was centrifuged at 
4,000 rpm for 5 min and the leukocyte pellet was dis-
solved with 0.5 ml of the lysis buﬀ erｳ  and then cen-
trifuged and rinsed with physiological tampon (0.075 
M NaClｳ  0.025 M EDTA)ｴ  The cells were incubated 
in lysis buﬀ er containing 250 µl of TE-9 (500 Tris-
HCl pH 9.0ｳ  20 mM EDTAｳ  10 mM NaCl)ｳ  100 µl of 
10ｵ SDS and 20 µl of proteinase-K (10mg/ml) at 65 
°C for 1 hｴ  At the end of the incubationｳ  150 µl of 6 
M salt solution was addedｳ  shaken strongly and cen-
trifuged at 15,000 rpm for 10 minｴ  Supernatant was 
taken to a new tube and DNA was concentrated by 
adding 1 ml of absolute ethanolｴ  After the centrifu-
gation at 15,000 rpm for 5 minｳ  the DNA pellet was 
rinsed with 1 ml of 75ｵ ethanolｳ  dried by inverting 
the tube and dissolved in 200 µl of TE buﬀ er (1 mM 
Tris-HClｳ  1 mM EDTAｳ  pH 7.5)ｴ
　　The G-308A and C-850T polymorphisms in the 
promoter of the TNF-ｸ gene were genotyped by 
using a PCR-RFLP method as previously described 
[1ｳ  12ｳ  17ﾝ19]ｴ  The G-308A variants were geno-
typed by using primers designed to incorporate the 
polymorphic site at position －308 relative to the 
TNF-ｸ transcription start site [12] (Primers for 
G-308A polymorphism : F-5ｾ-GGGACACACAAG 
CATCAAGG -3 ｾ  ;  R -5 ｾ -AATAGGTTTTGA -
GGGCCATG-3ｾ)ｴ  This variant (A at －308) creates 
an NcoI (MBI Fermentasｳ  Lithuania) restriction site 
and can be diﬀ erentiated by size (126 for the TNF1 
allele and 142 for the TNF2 allele) on a 12ｵ poly-
acrylamide gelｴ  The PCR product (131 bp) of C-850T 
polymorphism was ampliﬁ ed with primers FM850 
(mismatch) and R850 [18] (Primers for C-850T 
polymorphism : F-5ｾ-AAGTCGAGTATGGGGACCC
CCCGTTAA-3ｾ ; R-5ｾ-CCCCAGTGTGTGGCCATA
TCTTCTT-3ｾ)ｴ  Subsequentlyｳ  the 131 bp PCR 
product was digested with HincII (MBI Fermentasｳ 
Lithuania) restriction enzyme and subjected to 12ｵ 
polyacrylamide gel electrophoresisｴ  In the case of a 
C allele at position －850ｳ  HincII digestion produces 
106 bp and 25 bp fragmentsｳ  whereas the 131 bp frag-
ment remains undigested when the T allele is located 
at this positionｴ  Statistical analyses for comparing 
individual allele and genotype frequencies were car-
ried out using the chi-square test (two-sided asymp-
totic p values) with SPSS 10.0 software and the 
level of statistical signiﬁ cance was deﬁ ned as 
p ＜ 0.05.
Results
　　The clinical characteristics of the eclampticsｳ 
pre-eclamptics and controls are shown in Table 1ｴ 
All women with eclampsia and pre-eclampsia and the 
controls were primigravidｴ  They were used for com-
parison to exclude the confounding eﬀ ect of parity on 
pregnancy outcomeｴ  In this studyｳ  there was a signif-
icant diﬀ erence between control-eclamptics and con-
trol-pre-eclampticsｴ  On averageｳ  deliveries occured 
4ﾝ5 weeks earlier in the pre-eclamptic and eclamptic 
women than in the controlsｴ
　　The genotyping data for the G-308A and C-850T 
polymorphisms are presented in Tables 2 and 3ｴ  We 
found a diﬀ erence among the TNF2 allele frequen-
cies of the eclampticsｳ  pre-eclamptics and controlsｴ 
No homozygous TNF2 genotype was found in the 
PE/E and control groupsｴ  In the heterozygotes 
(TNF1/TNF2 ＝ GA) the genotype frequency 
increases from control to eclamptic and pre-eclamptic 
individuals with frequencies in the order of 5ｳ  12.9ｳ 
and 13.3ｵｳ  respectivelyｴ  A 㸧2 analysis in a 2 × 2 
table showed a signiﬁ cant diﬀ erence between control-
pre-eclamptics (㸧2 ＝ 16.287 and p ＜ 0.001) and con-
trol-eclamptics (㸧2 ＝ 5.022 and p ＝ 0.025) (Table 2)ｴ
　　Similar results were obtained by comparing the 
allele frequenciesｴ  There was a signiﬁ cant diﬀ erence 
between both the control-preeclamptics (㸧2 ＝ 15.87 
and p ＜ 0.001 ; 2 × 2 table) and control-eclamptics 
allele frequencies (㸧2 ＝ 4.893 and p ＝ 0.027 ; 2 × 2 
table)ｴ  Two 㸧2 analyses between the eclamptic and 
pre-eclamptic individuals for comparing the genotype 
and allele frequencies did not show a signiﬁ cant dif-
ferenceｳ  respectively (㸧2 ＝ 0.007 and p ＝ 0.933 ;
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Age (years) 28.5 31.9 ＜0.001 30.1 ＜0.001
Pregnancy
BMI (kg/m2) 22.8 25 ＜0.001 24.9 ＜0.001
Systolic
BP (mmHg) 129 163 ＜0.001 162 ＜0.001
Diastolic
Bp (mmHg) 83 104 ＜0.001 103 ＜0.001
Gestational age at
delivery (weeks) 38.7 33.7 ＜0.001 34.7 ＜0.001
BPｳ  blood pressure ; Eｳ  eclampsia ; PEｳ  pre-eclampsia ; Cｳ  controlｴ
Table 2　　Genotype and allele distribution of the G-308A polymorphism in the TNF-ｸ gene in eclamptic, pre-eclamptic and 
control patients











n % N % n % n % n %
Eclamptic 34 87.2  5 12.9 ﾝ ﾝ  39  73 93.6  5 6.4  78
PE 98 86.7 15 13.3 ﾝ ﾝ 113 211 93.4 15 6.6 226
Controls 76 95  4 5 ﾝ ﾝ  80 156 97.5  4 2.5 160
㸧2＝16.287ｳ  p＜0.001 (2×2 with controls for PE)* 㸧2＝15.87ｳ  p＜0.001 (2×2 with controls for PE)*
㸧2＝5.022ｳ  p＝0.025 (2×2 with controls for E)* 㸧2＝4.893ｳ  p＝0.027 (2×2 with controls for E)*
*The signiﬁ cant 㸧2 statistics between controlsｳ  pre-eclamptics and eclamptics
Table 3　　Genotype and allele distribution of the C-850T polymorphism in the TNF-ｸ gene in eclampticｳ  pre-
eclamptic and control patients





n % n % n % n % n %
Eclamptic 16 40 17 42.5  7 17.5  40  49 61.3 31 38.8  80
PE 68 60.7 25 22.3 19 17 112 161 71.9 63 28.1 224
Controls 20 48.4 33 31.9 17 24.3  70  73 52.1 67 48 140
㸧2＝ 57.609ｳ  p＜0.001 (2×3 with controls for PE)* 㸧2＝34.951ｳ  p＜0.001(2×2 with controls for PE)*
*The signiﬁ cant 㸧2 statistics between controls and pre-eclamptics
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 㸧2 ＝ 0.006 and p ＝ 0.936 ; 2 × 2 tables)ｴ
　　A diﬀ erent genotype distribution of C-850T poly-
morphism was observed between the PE/E and con-
trol groupsｳ  with the frequency of variant TT geno-
type being reduced in the preeclamptic (17ｵ) and 
eclamptic groups (17.5ｵ) compared with the control 
(24.3ｵ)ｴ  A 㸧2 analysis in a 2 × 3 table showed a sig-
niﬁ cant diﬀ erence between the control and pre-
eclamptic samples with 㸧2 ＝ 57.609 and p ＜ 0.001 
(Table 3)ｴ  There was no signiﬁ cant diﬀ erence 
between the control and eclamptic patients (㸧2 ＝ 2.770 
and p ＝ 0.250)ｴ  The frequency of variant T allele 
was reduced in the preeclamptic (28.1ｵ) and eclamp-
tic groups (38.8ｵ) compared with the control (48ｵ)ｴ 
The same results with genotype frequencies were 
obtained by comparing the allele frequencies of the 
PE and controlsｴ  We found a signiﬁ cant diﬀ erence 
between the control and pre-eclamptic allele frequen-
cies (㸧2 ＝ 34.951 and p ＜ 0.001 ; 2 × 2 table)ｳ  while 
we found no signiﬁ cant diﬀ erence between the con-
trol and eclamptics (㸧2 ＝ 2.659 and p ＝ 0.103 ; 2 × 2 
table)ｴ
　　Table 4 shows a comparison of our results with 
those of previous reportsｴ  The genotype and allele 
distributions of the C-850T polymorphism diﬀ ered 
signiﬁ cantly between the pre-eclampsia group and the 
control group (p ＝ 0.003 and p ＝ 0.003ｳ  respectively)ｳ 
as previously reported (Heiskanen et alｴｳ  2002)ｴ  The 
genotype and allele distributions of the G-308A poly-
morphism diﬀ ered signiﬁ cantly between the eclampsia 
157TNF PolymorphismsJune 2007
Table 4　　Comparison of the genotype and allele frequencies of the TNF-ｸ gene promoter C-850T and G-308A polymorphisms 
among women with eclampsiaｳ  pre-eclampsia and healthy pregnant controls at 4 studies
TNF C-850T (%) TNF G-308A (%)
Genotype frequencies Allelefrequencies Genotype frequencies
Allele
frequencies







Control 83.5 13.9 2.6 90.4 9.6
PE 93.2 4.5 2.3 95.5 4.5
Kaiser et alｴ
2004
Control 67.0 29.0 4.0 81.5 18.5
PE 60.7 36.1 3.3 78.7 21.3
E 43.1 51.0 5.9 68.6 31.4
Saarela et alｴ
2005
Control 81.7 18.3 0.0 90.9 9.1
PE 72.9 24.1 3.0 85.0 15.0
Our results Control 48.4 31.9 24.3 52.1 48.0 95.0 5.0 0.0 97.5 2.5
PE 60.7 22.3 17.0 71.9 28.1 86.7 13.3 0.0 93.4 6.6
E 40.0 42.5 17.5 61.3 38.8 87.2 12.9 0.0 93.6 6.4
P-values for each study :
1ｴ The frequency of the T allele in the control group was 9.6%ｳ  whereas in the preeclamptic group it was 4.5%ｴ  p＝0.030 and 0.030 
for the genotype and allele data of PE-Control statistics respectively (Heiskanen et alｴｳ  2002)ｴ
2ｴ  A signiﬁ cant diﬀ erence between control and eclamptic samples for the genotype and allele data of heterozygotes (TNF1/
TNF2) with p＝0.025 (Kaiser et alｴｳ  2004)ｴ
3ｴ In the case of G-308A polymorphismｳ  there were no statistically signiﬁ cant diﬀ erences in the genotype distribution (p＝0.080)ｴ  
The frequency of the A allele was 15% in the preeclamptics and 9.1% among the controls (p＝0.046) (Saarela et alｴｳ  2005)ｴ
4ｴ We found a signiﬁ cant diﬀ erence between the control-preeclamptics (p＜0.001 and p＜0.001) and control-eclamptics (p＝0.025 
and p＝0.027) for the genotype and allele data of heterozygotes (GA) respectivelyｴ  We also found a signiﬁ cant diﬀ erence between 
the control-preeclamptics (p＜0.001 and p＜0.001) for the genotype and allele distribution of the C-850T polymorphism in the TNF-
ｸ geneｴ
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group and the control group (p ＝ 0.025 and p ＝ 0.025ｳ 
respectively)ｳ  as Kaiser et alｴ  reportedｴ  The geno-
type and allele distributions of the G-308A polymor-
phism did not diﬀ er signiﬁ cantly between the pre-
eclampsia group and the control group (p ＝ 0.046 and 
p ＝ 0.08ｳ  respectively)ｳ as Saarela et alｴ  (2005) 
reportedｴ
Discussion
　　This study analysing eclampsia and PE patients in 
a Turkish population with respect to the TNF-ｸ
-G-308A and C-850T promoter polymorphisms 
showed a signiﬁ cantly increased incidence of the 
TNF2 (AA) allele and a reduced variant T allele 
with PE and eclampsiaｴ
　　Although we found no association between body 
mass indexｳ  systolic bpｳ  diastolic bp and gestational 
age at delivery of preeclamptics and eclampticsｳ  ele-
vated prepregnancy body mass index and waist cir-
cumference have been strongly associated with pre-
eclampsia in previous studies [20ﾝ29]ｴ  In our studyｳ 
they are statistically related to the diseases com-
pared with the controlsｴ  Women with preeclampsia 
and eclampsia were of higher socioeconomic statusｳ 
and this likely biased the relationship between body 
mass index and preeclampsia toward the null in our 
studyｴ  Obesity is associated with chronic inﬂ amma-
tion and oxidative stress [29ｳ  30]ｴ  Thusｳ  elevated 
body fat may trigger excessive cytokine production 
among genetically susceptible pregnant women [29]ｴ
　　Our ﬁ ndings of a signiﬁ cantly increased incidence 
of the TNF2 allele and an approximately equal inci-
dence of the TNF1 with controls is in contrast with 
Chen et alｴ  (1996)ｳ  who found a signiﬁ cantly higher 
incidence of the TNF1 allele in PE patients com-
pared with controls [31]ｴ  Howeverｳ  some research-
ers found no signiﬁ cant diﬀ erence in the allele fre-
quencies of the G-308A polymorphism between 
PE/E and controls [1ｳ  32ﾝ34]ｴ  The relationship 
between the G-308A polymorphism and PE has 
recently been described by Haggerty et alｴ  (2005) 
[29]ｴ  Analysing eclampsia and PE separatelyｳ  we 
found that the genotype frequencies of the TNF2 in 
our pre-eclamptic and eclamptic groups was signiﬁ -
cantly higher than the controlsｳ  while no signiﬁ cant 
diﬀ erence was found between the eclamptic and PE 
patientsｴ  In agreement with our ﬁ ndingsｳ  the study 
undertaken by Kaiser et alｴ  (2004) did not diﬀ erenti-
ate between eclamptic and PE patientsｳ  but they ana-
lysed only G-308A promoter polymorphism in their 
study [1]ｴ  In the study of Saarela et alｴ  (2005)ｳ  the 
less frequent A allele (TNF2) of the G-308A poly-
morphism was found to be associated with an 
increased risk of pre-eclampsia in Finnish women 
[35]ｳ  but there were no statistically signiﬁ cant dif-
ferences in the genotype and allele distribution 
between the pre-eclamptics and controlsｴ  The pres-
ence of the allele A leads to expression of the TNF2 
variant and is correlated with the PEｴ  With reporter 
genes under the control of the 2 allelic TNF promot-
ers (TNF1 and TNF2)ｳ  TNF2 is a much stronger 
transcriptional activator than the common allele 
(TNF1) [36] and could contribute to the upregula-
tion of various genes involved in PE diseaseｴ  The 
signiﬁ cant increase in the TNF2 allele in eclamptic 
patients could indicate that a higher expression of 
TNF-ｸ promotes the progression from PE to eclamp-
siaｴ
　　It is generally accepted that PE and eclampsia 
are expressions of the same syndromeｳ  with eclamp-
sia being the fulminating form of PEｴ  Their pathol-
ogy is commonｳ  and PE is a mild case of eclampsiaｴ 
In our studyｳ  the T allele occurred at a lower fre-
quency in PE than in eclampsiaｴ  While the T allele 
is PE＜eclampsia＜normalｳ  the CC genotype is PE
＞normal＞eclampsiaｴ  Our data does not imply that 
the T allele exerts a protective eﬀ ect against this 
pathologyｴ  On the other handｳ  according to the 
results of  PE＜normal for the T alleleｳ  Heiskanen 
et alｴ  (2002) reported that the C-850T allele may be 
protective against the development of PE [19]ｴ  A 
lower incidence of the T genotype compared with the 
controls found in PE in present study is not the ﬁ rst 
exampleｳ  but it is the ﬁ rst in eclampsiaｴ  In this 
studyｳ  there was a signiﬁ cant diﬀ erence between the 
control and pre-eclamptic genotypes for C-850T poly-
morphismｳ  while there was no signiﬁ cant diﬀ erence 
between control and eclamptics [19]ｴ  The genotype 
and allele distributions of the C-850T polymorphism 
diﬀ ered signiﬁ cantly between the pre-eclampsia 
group and the control group as previously reported 
(Heiskanen et alｴｳ  2002)ｴ
　　Hayashi et alｴ  (2005) demonstrated no signiﬁ cant 
increase in TNF-ｸ levels in the placenta in pre-
eclampsia despite a signiﬁ cant increase in the serum 
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TNF-ｸ levels [37]ｴ  These ﬁ ndings suggest that 
TNF-ｸ in the placenta is not a key cytokine that 
interferes with normal trophoblast invasion into the 
myometrium in pre-eclampsiaｳ  and that sources other 
than the placenta may be contributing to the elevated 
levels of TNF-ｸ found in the circulation of pre-
eclamptic patientsｴ  Freeman et alｴ  (2004) found that 
TNF-ｸ levels were increased by 33ｵ between the 
ﬁ rst and third trimeters in pre-eclamptic pregnanciesｴ 
They concluded from this study that pre-eclampsia is 
associated with short and long-term changes in 
inﬂ ammatory status [38]ｴ
　　The primary strength of our study is that we 
examined 2 polymorphisms in the promoter region of 
the TNF-ｸ gene in a group of Turkish pre-eclamptic/
eclamptic womenｳ  which allowed us to gain an under-
standing of whether population susceptibility for 
PE/eclampsia in this population was diﬀ erent from 
those in other populationsｴ  A weakness of our study 
is that the data observed was obtained from a limited 
population (Turkish women)ｴ  The main limitation of 
the study is the lack of circulating cytokine measures 
that are needed to prove a functional relationship 
between polymorphismsｳ  elevated cytokinesｳ  and 
PE/eclampsiaｴ
　　In summaryｳ  we have demonstrated an association 
between TNF-ｸ polymorphisms and pre-eclampsia 
susceptibilityｴ  It is not known whether C-850T poly-
morphism has a functional eﬀ ect on the TNF-ｸ geneｳ 
but we could not say that this polymorphism pro-
motes the progression from PE to eclampsiaｴ  It is 
true that susceptibility in Turkey for PE/eclampsia 
may be diﬀ erent from other casesｴ  There have been 
some additional reports on TNF-ｸ polymorphism and 
PE/eclampsiaｴ  A possible reason for the inconsis-
tency among these reports may be a genetic basis 
that causes diﬀ erent susceptibilities among diﬀ erent 
populationsｴ  The mechanisms behind this ﬁ nding 
remain to be determinedｴ
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